TATIANA VALDERRAMA: Open Payments
NPI 1831423052 · NEWARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,178 in 59 payments from 18 companies in 2025. Trend: 2023 $1,782 · 2024 $1,831 · 2025 $1,178
Food & beverage: $1,089Education: $89
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $216 |
| Janssen Biotech, Inc. | 8 | $212 |
| REVANCE THERAPEUTICS, INC. | 1 | $148 |
| Aimmune Therapeutics, Inc. | 5 | $91 |
| Phathom Pharmaceuticals, Inc. | 5 | $81 |
| GENZYME CORPORATION | 3 | $57 |
| Lilly USA, LLC | 3 | $56 |
| Ardelyx, Inc. | 3 | $53 |
| Madrigal Pharmaceuticals | 3 | $53 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
Products named: TREMFYA, DAXXIFY, RINVOQ, DUPIXENT, ZENPEP, VOQUEZNA, OMVOH, IBSRELA.
Industry payments across NJ — which companies pay providers there.
